Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ramipril mechanism study in adults at high cardiovascular risk
ACTRN12606000003572Phase 4Completed
- Sponsor
- Queen Elizabeth Hospital
- Start
- Jan 2003
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of ramipril in cardiac morbidity, coronary arteriosclerosis, peripheral artery occlusion (PAD) and 2 more (2 arms), sponsored by Queen Elizabeth Hospital. Primary endpoint: Changes in platelet responsiveness to sodium nitroprusside. Started Jan 2003; status: completed.
02
Drugs
ramipril
03
Conditions
cardiac morbiditycoronary arteriosclerosisperipheral artery occlusion (PAD)stroketype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on ACTRN12606000003572.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12606000003572.